Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts
A. Benedict Cosimi(Massachusetts General Hospital), Paul S. Russell(Harvard University), Patrick C. Kung(Columbia University Irving Medical Center), Francis L. Delmonico(Massachusetts Medical Society), Gideon Goldstein, Robert H. Rubin(Massachusetts General Hospital), W. Hansen, Robert C. Burton, Robert B. Colvin(Harvard University)
Cited by 513
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k